Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael D. Wyatt is active.

Publication


Featured researches published by Michael D. Wyatt.


British Journal of Cancer | 1997

Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9.

Stuart G. M. Bailey; Michael D. Wyatt; Frank Friedlos; John A. Hartley; Richard J. Knox; Alexander D. Lewis; Paul Workman

The chemistry of the mitomycin C-related drug indoloquinone EO9 would suggest that its mechanism of action is likely to involve DNA damage after reductive activation. The ability of this agent to induce DNA damage in intact cells has been examined using alkaline filter elution. After treatment with pharmacologically relevant concentrations of EO9, both DNA strand breaks and interstrand cross-links were detected in rat Walker tumour cells and human HT29 colon carcinoma cells. These cell lines express relatively high levels of DT-diaphorase (NAD(P)H: quinone acceptor oxidoreductase), which is believed to be involved in EO9 activation. The extent of DNA damage was increased by approximately 30-fold under hypoxia in BE colon carcinoma cells that express non-functional DT-diaphorase, but this dramatic hypoxia enhancement was not seen in HT-29 cells. These data are consistent with cytotoxicity studies that indicate that DT-diaphorase appears to be important in EO9 activation under aerobic conditions, but other enzymes may be more relevant under hypoxia. The involvement of DT-diaphorase in DNA damage induction was further investigated using cell-free assays. DNA cross-links were detectable in plasmid DNA co-incubated with EO9, cofactor and DT-diaphorase but not in the absence of this enzyme. In contrast, using a Taq polymerase stop assay, monofunctional alkylation was detected in plasmid DNA without metabolic activation, although the sequence selectivity was altered after reduction catalysed by DT-diaphorase.


Bioorganic & Medicinal Chemistry Letters | 1994

Synthesis and DNA binding properties of a series of N to C linked and imidazole containing analogues of distamycin

Michael D. Wyatt; Bonnie J. Garbiras; Moses Lee; Stephen M. Forrow; John A. Hartley

Abstract A series of imidazole containing analogues linked in a head to tail fashion (N to C) and containing methylene linkers were synthesized and examined for their DNA binding properties. The triimidazole β-alanine linked compound 10a was shown to bind efficiently to GC rich sites on DNA covering six base pairs, which is in contrast to the tetraimidazole carboxamide compound 3 , previously shown to be a poor DNA binder.


Bioorganic & Medicinal Chemistry Letters | 1994

Probing the importance of the second chloroethyl arm of a benzoic acid mustard derivative of an imidazole-containing analogue of distamycin

John A. Hartley; Michael D. Wyatt; Bonnie J. Garbiras; Celese Richter; Moses Lee

The synthesis and biological evaluation of a half mustard derivative of an imidazole-containing analogue of distamycin 3 are described. Although binding efficiently to naked DNA the half mustard has a dramatically reduced cytotoxicity, and shows a distinctly different sequence specificity of alkylation from the parent mustard.


Bioorganic & Medicinal Chemistry | 1995

Novel cytotoxic DNA sequence and minor groove targeted photosensitizers: Conjugates of pyrene and netropsin analogues

John A. Hartley; Joanne Webber; Michael D. Wyatt; Natalie Bordenick; Moses Lee

The design, syntheses, photochemical and biological properties of conjugates of pyrene with pyrrole- (1) and imidazole-containing (2) analogues of netropsin are reported. The results of an ethidium displacement assay and circular dichroism (CD) titration studies show both compounds bind with a higher affinity to poly(dA-dT) than to poly(dG-dC). In addition they bind as strongly to T4 coliphage DNA as to calf thymus DNA suggesting the binding occurs in the minor groove. The quenching rate constants of the singlet excited states of agents 1 and 2 by molecular oxygen were found to be 8.5 x 10(9) M-1S-1 and 7.7 x 10(9) M-1S-1, suggesting the involvement of singlet oxygen. Both compounds showed some cytotoxicity to human chronic myeloid leukemia K562 cells in the dark. Upon irradiation the activities were significantly enhanced resulting in photoinduced dose modifications of 8 and 14 for 1 and 2, respectively under the conditions employed. Both agents were markedly more phototoxic than 1-pyrenebutyric acid 8. To address the mechanism of action of compounds 1 and 2 their photoactivated abilities to produce DNA strand breaks were measured. Both agents caused increased single strand breakage with increasing UV exposure. The concentrations (EC50) of 1 and 2 needed to cause 50% single-strand cleavage of pBR322 DNA upon UV-A activation were found to be 40 microM and 45 microM, respectively. In contrast, no DNA strand breaks were observed in the dark with either conjugate or with 8 following irradiation. DNA strand breaks were measured in drug treated K562 cells using alkaline elution.(ABSTRACT TRUNCATED AT 250 WORDS)


Journal of Medicinal Chemistry | 2015

Iterative Conversion of Cyclin Binding Groove Peptides into Druglike CDK Inhibitors with Antitumor Activity

Padmavathy Nandha Premnath; Sandra Craig; Shu Liu; Erin L. Anderson; Asterios I. Grigoroudis; George Kontopidis; Tracy Perkins; Michael D. Wyatt; Douglas L. Pittman; Campbell McInnes

The cyclin groove is an important recognition site for substrates of the cell cycle cyclin dependent kinases and provides an opportunity for highly selective inhibition of kinase activity through a non-ATP competitive mechanism. The key peptide residues of the cyclin binding motif have been studied in order to precisely define the structure–activity relationship for CDK kinase inhibition. Through this information, new insights into the interactions of peptide CDK inhibitors with key subsites of the cyclin binding groove provide for the replacement of binding determinants with more druglike functionality through REPLACE, a strategy for the iterative conversion of peptidic blockers of protein–protein interactions into pharmaceutically relevant compounds. As a result, REPLACE is further exemplified in combining optimized peptidic sequences with effective N-terminal capping groups to generate more stable compounds possessing antitumor activity consistent with on-target inhibition of cell cycle CDKs. The compounds described here represent prototypes for a next generation of kinase therapeutics with high efficacy and kinome selectivity, thus avoiding problems observed with first generation CDK inhibitors.


Biochemistry | 1993

GC base sequence recognition by oligo(imidazolecarboxamide) and C-terminus-modified analogues of distamycin deduced from circular dichroism, proton nuclear magnetic resonance, and methidiumpropylethylenediaminetetraacetate-iron(II) footprinting studies

Moses Lee; Andrea L. Rhodes; Michael D. Wyatt; Stephen M. Forrow; John A. Hartley


Nucleic Acids Research | 1995

DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin

Massimo Broggini; Helen M. Coley; Nicola Mongelli; Enrico Pesenti; Michael D. Wyatt; John A. Hartley; Maurizio D'Incalci


Journal of Medicinal Chemistry | 1994

GC SEQUENCE-SPECIFIC RECOGNITION BY AN N-FORMAMIDO, C-TERMINUS-MODIFIED AND IMIDAZOLE-CONTAINING ANALOG OF NETROPSIN

Moses Lee; Christopher S. Preti; Emily Vinson; Michael D. Wyatt; John A. Hartley


Methods of Molecular Biology | 1997

Determination of the DNA sequence specificity of alkylation damage using cleavage-based assays.

John A. Hartley; Michael D. Wyatt


Nucleic Acids Research | 1997

The sequence specificity of alkylation for a series of benzoic acid mustard and imidazole-containing distamycin analogues: the importance of local sequence conformation

Michael D. Wyatt; Moses Lee; John A. Hartley

Collaboration


Dive into the Michael D. Wyatt's collaboration.

Top Co-Authors

Avatar

John A. Hartley

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Douglas L. Pittman

University of Toledo Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anusha Chaparala

University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Campbell McInnes

University of South Carolina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Deepak Poudyal

University of South Carolina

View shared research outputs
Researchain Logo
Decentralizing Knowledge